Whileglycosylation variants of APOC3 have been reported to occur in breastcancer58 and lung cancer,59 to our knowledge, our study is the first to demonstrateglycosylation differences of APOC3 in NASH and HCC. This evidence concerns the gene APOC3 and metabolic dysfunction-associated steatohepatitis.